| Fiscal period | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Period End Date | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 |
|---|
| Revenue: Services | 160.94 | 159.34 | 142.64 | 186.90 | 224.44 | 244.52 | 258.45 | 266.94 | 252.58 | 258.04 |
| Revenue: Products | 279.18 | 328.73 | 395.40 | 428.74 | 332.80 | 384.58 | 429.22 | 379.13 | 380.38 | 408.12 |
| Total Revenues | 440.12 | 488.07 | 538.03 | 615.64 | 557.24 | 629.09 | 687.66 | 646.07 | 632.97 | 666.16 |
| Cost of sales: Products | 175.86 | 203.26 | 237.39 | 245.17 | 227.68 | 229.82 | 229.79 | 203.53 | 195.43 | 243.64 |
| Cost of sales: Services | 100.08 | 88.39 | 86.41 | 106.69 | 106.18 | 121.23 | 133.47 | 137.70 | 127.79 | 130.72 |
| Gross Profit | 164.18 | 196.42 | 214.23 | 263.78 | 223.38 | 278.04 | 324.39 | 304.84 | 309.75 | 291.81 |
| Impairment of goodwill and other intangible assets | -- | 302.79 | -- | -- | 48.30 | -- | -- | -- | -- | 537.18 |
| Research and development | 86.48 | 89.47 | 87.07 | 69.15 | 74.14 | 80.79 | 95.30 | 94.63 | 88.40 | 92.77 |
| Selling, general and administrative | 210.13 | 210.17 | 244.18 | 227.70 | 219.90 | 254.36 | 272.29 | 264.19 | 259.78 | 303.78 |
| Asset impairment charges | (144.97) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Severance and other Restructuring cost | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | 441.58 | 602.43 | 331.25 | 296.85 | 342.34 | 335.15 | 367.59 | 358.81 | 348.17 | 933.73 |
| Operating Income (Loss) | (277.40) | (406.00) | (117.02) | (33.07) | (118.96) | (57.10) | (43.19) | (53.97) | (38.42) | (641.92) |
| Interest expense (income) and other | 2.56 | (43.69) | 3.79 | (352.61) | 24.45 | 8.00 | 0.04 | 3.55 | 1.39 | 13.03 |
| Interest income | 7.30 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Foreign exchange gain (loss), net | 2.45 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain on arbitration settlement | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other income, net | 20.21 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income (loss) before income taxes | (250.00) | (362.31) | (120.81) | 319.54 | (143.41) | (65.10) | (43.23) | (57.52) | (39.81) | (654.95) |
| Current- U.S. Federal | 0.02 | 0.14 | 0.12 | (8.68) | 1.29 | -- | (5.88) | (0.08) | (2.11) | 10.75 |
| Current- Foreign | 2.82 | 1.69 | 5.04 | 6.86 | 5.65 | -- | 10.62 | 12.71 | 8.10 | 0.93 |
| Current: State | 0.30 | (0.05) | (0.50) | 2.10 | 0.45 | -- | 0.29 | -- | 0.03 | 0.17 |
| Provision (benefit) for income taxes | 2.19 | (0.64) | 2.14 | (2.51) | 6.18 | 4.53 | 2.04 | 7.80 | (0.55) | 8.97 |
| Deferred: State | -- | -- | -- | -- | -- | -- | 0.00 | 0.74 | -- | (0.23) |
| Deferred: Foreign | (0.95) | (2.41) | (2.52) | (2.80) | (1.27) | -- | (2.67) | (6.66) | (5.32) | 2.60 |
| Deferred- U.S. Federal | -- | -- | 0.00 | -- | 0.07 | -- | (0.32) | 0.00 | (1.25) | (5.25) |
| Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Domestic | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| (Loss) on equity method investment | (3.40) | (1.28) | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income (loss) before cumulative effect of changes in accounting principles | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect on expensing legal fees as incurred | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in amortization method for patents and license costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Consolidated Net Income (loss) | (255.59) | (362.95) | (122.95) | 322.05 | (149.59) | (69.63) | (45.26) | (65.32) | (39.27) | (663.93) |
| Less- Net income attributable to noncontrolling interest | -- | (0.27) | (0.24) | -- | -- | 0.25 | 0.24 | 0.87 | (0.85) | (8.43) |
| Redeemable non-controlling interest redemption value in excess of carrying value | -- | 0.48 | 0.60 | -- | -- | -- | -- | -- | -- | -- |
| Preferred stock dividends and accretion of unamortized issuance costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (loss) Available to Common Shareholders | (255.59) | (363.17) | (123.31) | 322.05 | (149.59) | (69.88) | (45.51) | (66.19) | (38.42) | (655.49) |
| Income (loss) per share before cumulative effect of changes in accounting principles | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect on prior years: Expensing legal fees as incurred per share | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect on prior years: Change in amortization method for patents and license costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | (1.94) | (2.79) | (0.96) | 2.62 | (1.27) | (0.61) | (0.41) | (0.59) | (0.35) | (5.85) |
| Net Earnings Per Share (Diluted) | (1.94) | (2.79) | (0.96) | 2.55 | (1.27) | (0.61) | (0.41) | (0.59) | (0.35) | (5.85) |
| Weighted Average Shares Outstanding (Basic) | 131.86 | 129.94 | 127.82 | 122.87 | 117.58 | 113.81 | 112.33 | 111.55 | 111.19 | 111.97 |
| Weighted Average Shares Outstanding (Diluted) | 131.86 | 129.94 | 127.82 | 126.33 | 117.58 | 113.81 | 112.33 | 111.55 | 111.19 | 111.97 |